Carvajal VG

Idioma: Español
Referencias bibliográficas: 29
Paginas: 69-73
Archivo PDF: 348.01 Kb.

RESUMEN

Presentamos el caso de un paciente de 73 años de edad referido a nuestra consulta de cuidados paliativos por un cáncer de pulmón metastásico no candidato a terapia curativa, que presenta disnea refractaria a tratamiento. La disnea es un problema frecuente para los pacientes con condiciones terminales y estrategias clínicas efectivas pueden aliviar el síntoma en la mayoría de los casos. El manejo sintomático puede llevarse a cabo concomitantemente con la corrección de la causa de fondo cuando esto esté justificado.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE 2nd, Marcello J, Young IH, Bull J, Wilcock A, Booth S, Wheeler JL, Tulsky JA, Crockett AJ, Currow DC. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet. 2010;376(9743):784-793.

2. American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med. 1999;159(1):321–40.

3. Bausewein C, Booth S, Gysels M, Higginson I. Nonpharmacological interventions for breathlessness in advanced stages of malignant and nonmalignant diseases. 2008.

4. Benitez-Rosario MA, Feria M. Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients. Journal of Palliative and Symptom Management. 2005;30:395-397.

5. Borg G. Perceived Exertion as an indicator of somatic stress. Scandinavian journal of Rehabilitation Medicine. 1970;2(2):92-98.

6. Bruera E, Kuehn N, Miller MJ, et al. The edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7:6-9.

7. Bruera E, Schmitz B, Pither J. The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage. 2000;19(5):357-362.

8. Buckholz GT, von Gunten CF. Nonpharmacological management of dyspnea. Current Opinion in Supportive and Palliative Care. 2009;3:98–102.

9. Campbell M, Templin T, Walch J. Patients Who Are Near Death Are Frequently Unable To Self-Report Dyspnea. Journal of palliative medicine. 2009;12(10).

10. Chang, V.T. et al. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center. Cancer. 2000;88:1175-1183.

11. Chochinov HMC. Psychiatry and the terminally ill. Canadian Journal of Psychiatry. 2000;45:143-150.

12. Clary PL. Pharmacologic pearls for end-of-life care. Am fam Phys. 2009;79:1059-1065.

13. Cranston JM, Crockett A, Moss J, Alpers JH. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2005.

14. Crisafulli E, Costi S, De Blasio F, et al. Effects of a walking aid in COPD patients receiving oxygen therapy. Chest. 2007;131:1068–1074.

15. Donesky-Cuenco D, Nguyen H, Paul S, Carrieri-Kohlman V. Yoga Therapy Decreases Dyspnea-Related Distress and Improves Functional Performance in People with Chronic Obstructive Pulmonary Disease: A Pilot Study. The journal of alternative and complementary medicine. 2009;15(3):225–234.

16. Dudgeon DJ, Kristjanson L, Sloan JA, Lertzman M, Clement K. Dyspnea in cancer patients: prevalence and associated factors. J Pain Symptom Manage. 2001;2:95–102.

17. Hayes AW, Philip J, Spruyt OW. Patient reporting and doctor recognition of dyspnoea in a comprehensive cancer centre. Intern Med J. 2006;36(6):381-384.

18. Higginson I, McCarthy M. Measuring symptoms in terminal cancer: are pain and dyspnoea controlled? J R Soc Med. 1989;82(5):264–267.

19. Hosakote S, Raghavendra M, HongasanDISNEAdra R, et al. Effects of yoga on symptom management in breast cancer patients: A randomized controlled trial .Int J Yoga. 2009;2(2):73-79.

20. Jackson KC, Lipman AG. Drug therapy for anxiety in adult palliative care patients. Cochrane Database of Systematic Reviews. 2004;1.

21. Jennings AJ, Davies AN, Higgins JPT, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57:939-944.

22. Kallet R. The Role of Inhaled Opioids and Furosemide for the Treatment of Dispnoea. Respir Care. 2007;52(7):900-910.

23. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006.

24. Mador MJ, Kufel TJ. Reproducibility of visual analogue scale measurements of dyspnea in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992;146:82-87.

25. Mercadante S, Casuuccio A, Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage. 2000;20(2):104–112.

26. Moore RP, Berlowitz DJ, Denehy L, Pretto JJ, Brazzale DJ, Sharpe K, Jackson B, McDonald CF. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax. 2010.

27. Pomidori L, Campigotto F, Amatya TM, Bernardi L, Cogo A. Efficacy and tolerability of yoga breathing in patients with chronic obstructive pulmonary disease: a pilot study. J Cardiopulm Rehabil Prev. 2009;29:133-137.

28. Thomas JR, von Gunten F. Management of Dyspnea. J Support Oncol. 2003;1(1):23–34.

29. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11:1133-1153.